Review



spectrochip array  (agena bioscience)


Bioz Verified Symbol agena bioscience is a verified supplier
Bioz Manufacturer Symbol agena bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    agena bioscience spectrochip array
    Spectrochip Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/spectrochip/pm40577992-87-11-13
    Average 90 stars, based on 1 article reviews
    spectrochip array - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Polymerase Chain Reaction:

    Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
    Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007].

    Article Title: Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients.
    Article Snippet: Finally, the samples were desalted using resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience), analyzed by MALDI-TOF-MS, and processed using SpectroTYPER version 4.0 software (Agena Bioscience).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p>
    Article Snippet: Following the PCR reaction, SAP addition, and iPLEX Pro extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by MassARRAY® System, and ultimately interpreted on SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
    Article Snippet: Circulating tumor DNA (ctDNA) is the cornerstone of liquid biopsy diagnostics, revealing clinically relevant genomic aberrations from blood of cancer patients.. Genomic analysis of single circulating tumor cells (CTCs) could provide additional insights into intrapatient heterogeneity, but it requires whole-genome amplification (WGA) of DNA, which might introduce bias.. Here, we describe a novel approach based on mass spectrometry for mutation detection from individual CTCs not requiring WGA and complex bioinformatics pipelines.

    Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Mass Spectrometry:

    Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
    Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007].

    Article Title: Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients.
    Article Snippet: Finally, the samples were desalted using resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience), analyzed by MALDI-TOF-MS, and processed using SpectroTYPER version 4.0 software (Agena Bioscience).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p>
    Article Snippet: Following the PCR reaction, SAP addition, and iPLEX Pro extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by MassARRAY® System, and ultimately interpreted on SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
    Article Snippet: Circulating tumor DNA (ctDNA) is the cornerstone of liquid biopsy diagnostics, revealing clinically relevant genomic aberrations from blood of cancer patients.. Genomic analysis of single circulating tumor cells (CTCs) could provide additional insights into intrapatient heterogeneity, but it requires whole-genome amplification (WGA) of DNA, which might introduce bias.. Here, we describe a novel approach based on mass spectrometry for mutation detection from individual CTCs not requiring WGA and complex bioinformatics pipelines.

    Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Software:

    Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
    Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007].

    Article Title: Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients.
    Article Snippet: Finally, the samples were desalted using resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience), analyzed by MALDI-TOF-MS, and processed using SpectroTYPER version 4.0 software (Agena Bioscience).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p>
    Article Snippet: Following the PCR reaction, SAP addition, and iPLEX Pro extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by MassARRAY® System, and ultimately interpreted on SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).

    Article Title: Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
    Article Snippet: Circulating tumor DNA (ctDNA) is the cornerstone of liquid biopsy diagnostics, revealing clinically relevant genomic aberrations from blood of cancer patients.. Genomic analysis of single circulating tumor cells (CTCs) could provide additional insights into intrapatient heterogeneity, but it requires whole-genome amplification (WGA) of DNA, which might introduce bias.. Here, we describe a novel approach based on mass spectrometry for mutation detection from individual CTCs not requiring WGA and complex bioinformatics pipelines.

    Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer.
    Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto SpectroCHIP® Arrays (Agena Bioscience, San Diego, CA), analyzed by mass spectrometry, and ultimately interpreted using SpectroTYPER v4.0 software (Agena Bioscience, San Diego, CA).



    Similar Products

    90
    agena bioscience spectrochip array
    Spectrochip Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/spectrochip/pm40577992-87-11-13
    Average 90 stars, based on 1 article reviews
    spectrochip array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    96
    agena bioscience cpm 384 spectrochip array
    Cpm 384 Spectrochip Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/SpectroCHIP+CPM/pm40564679-74-7-11
    Average 96 stars, based on 1 article reviews
    cpm 384 spectrochip array - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    agena bioscience spectrochip®ii-g384 array
    Spectrochip®Ii G384 Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/spectrochip+g384/pm40015360-82-9-11
    Average 90 stars, based on 1 article reviews
    spectrochip®ii-g384 array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    96
    agena bioscience spectrochip cpm 384 array
    Spectrochip Cpm 384 Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/SpectroCHIP+CPM/pm39704823-90-26-34
    Average 96 stars, based on 1 article reviews
    spectrochip cpm 384 array - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    Sequenom spectrochip array
    Spectrochip Array, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/spectrochip/pmc11745869-137-9-12
    Average 90 stars, based on 1 article reviews
    spectrochip array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    agena bioscience 96-spectrochip® array
    96 Spectrochip® Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/384+spectrochip/pm39550978-84-8-10
    Average 90 stars, based on 1 article reviews
    96-spectrochip® array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    agena bioscience 96-spectrochip ® array
    96 Spectrochip ® Array, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spectrochip%C2%AE+arrays/384+spectrochip/pmc11460119-187-17-20
    Average 90 stars, based on 1 article reviews
    96-spectrochip ® array - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results